Tiziana Life Sciences Appoints New Chief Executive Officer

Tiziana Life Sciences Appoints New Chief Executive Officer

by | 19 August 2024 | News

NEW YORK, August 19, 2024 – Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3...